REQUEST A DEMO
Total
USD $0.00
Search more companies

Osher Biotecnologica Sas (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Osher Biotecnologica Sas Profile Updated: May 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Osher Biotecnologica Sas is an enterprise based in Colombia. Its main office is in Bogota D.C.. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on August 24, 2021. 21 (2024) employees currently work for Osher Biotecnologica Sas. From the latest financial highlights, Osher Biotecnologica Sas reported a net sales revenue increase of 32.51% in 2023. A growth of 55.72% was recorded in its total assets. Osher Biotecnologica Sas’s net profit margin increased by 3.16% in 2023.

Headquarters
Cl 102 # 70B - 57
Bogota D.C.; Bogota D.C; Postal Code: 0906

Contact Details: Purchase the Osher Biotecnologica Sas report to view the information.

Basic Information
Total Employees:
Purchase the Osher Biotecnologica Sas report to view the information.
Outstanding Shares:
Purchase the Osher Biotecnologica Sas report to view the information.
Incorporation Date:
August 24, 2021
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Osher Biotecnologica Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
32.51%
Total operating revenue
32.51%
Operating profit (EBIT)
64.06%
Net Profit (Loss) for the Period
64.06%
Total assets
55.72%
Total equity
84.78%
Operating Profit Margin (ROS)
3.16%
Net Profit Margin
3.16%
Return on Equity (ROE)
-5.09%
Quick Ratio
0.72%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?